Norbrook Laboratories, Ltd. announced the availability of new Enroflox® 100 (enrofloxacin) for swine
New Enroflox 100 is effective against four major SRD-causing bacteria, including Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis. Enrofloxacin has quickly become the choice of swine veterinarians and pork producers to treat and control SRD since its introduction in 2008.
“Swine veterinarians, integrators and producers have been anxiously waiting for the return of Enroflox 100 to the market as a cost-effective alternative to the popular Baytril 100. We are excited to bring back this new swine labeled generic version to the swine segment” announces Chip Whitlow, Marketing Manager, Norbrook, Inc. “The big difference veterinarians, integrators and swine producers will notice is the lower per-dose cost in swine when compared to Baytril 100.”
Enroflox 100 will be available from veterinarians in 100 mL and 250 mL bottles to fit any size operation. For more information about new Enroflox 100, contact your veterinarian or local animal health products supplier or Norbrook, Inc. at www.norbrookinc.com.
For use by or on the order of a licensed veterinarian. Federal law prohibits the extra-label use of this drug in food-producing animals. Swine intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose. Use with caution in swine with known or suspected CNS disorders. Observe label directions and withdrawal times. See product labeling for full product information.
Baytril is a registered trademark of Bayer